SpayVac
SpayVac is a biotechnology company specializing in innovative, breeding control using an injectable birth control vaccine. Using their proprietary vaccine nanoparticle platform, SpayVac provides single-dose, long-term fertility control for production animals, such as swine, farm-raised fish, companion animals, and various feral and wild species. Their technology leverages immunocontraception. The nanoparticle delivery platform creates a robust and efficient immune response reducing the need for booster vaccines
- About their product/solution: Proprietary liposomal technology for single-dose vaccines
- No. of employees: 6
- HQ: Madison, Wisconsin, USA
- Founded in: 2019
- Raised so far: $1.25M
- Backed by: Angel investors
- Looking to engage with: Potential partners and investors.